On October 6th, Benefit Pharmaceutical successfully held the "2025 Strategic Operation Advanced Communication Meeting". The meeting aimed to summarize and review the implementation of the 2024 strategy and the development of key projects, insight into the " time" and " trend" of market development, sort out and plan the work deployment for 2025, and formulate new strategic goals and paths for Benefit in the coming year.

PART·1 Combat Effectiveness Evaluation

The first item on the meeting agenda was the combat effectiveness evaluation of excellent teams. Teams are our cornerstone, and team leaders are the beacons guiding the team forward. This evaluation form, from the four dimensions of execution, integration, sense of responsibility, and sense of crisis, aims to help us clearly recognize the advantages and disadvantages of our own teams. It is not only a test of the team but also a profound reflection on self-management ability. It is hoped that all senior executives will demand themselves with higher standards, lead the team with a broader vision, and jointly create a more brilliant future for Benefit.

PART·2 Sectional Reports

Subsequently, targeted solutions were formulated based on dialectical analysis. Heads of various sections took turns to take the stage, comprehensively introducing the 2024 operation status with detailed data and vivid cases. From production quality to market promotion, from procurement management to internal service, every link demonstrated the professional strength and remarkable results of Benefit Pharmaceutical. Meanwhile, they also shared the 2025 strategic advancement plans, which are closely aligned with industry trends and highly innovative, injecting new vitality into the company's sustainable development.

PART·3 Chairman's Speech

At the meeting, Chairman Wu Lihua delivered a keynote speech. The chairman profoundly analyzed the current domestic environment and economic situation. He pointed out that in the face of the increasing uncertainty of the industry environment and the trend of intensified competition, only through continuous innovation and keeping pace with the times can we seize development opportunities in the new era and achieve steady progress of the enterprise. 2025 is the concluding year of the company's sixth three-year strategic plan. In the strategic layout, the chairman particularly emphasized the core strategic concept of " three excellences, two cores, and one foundation", namely excellent products, excellent services, excellent talents, with marketing and innovation as the core, and profits as the foundation. The chairman stated that in the journey of pursuing excellent quality, Benefit should break the shackles of traditional thinking, demonstrate innovation and vitality, and bring higher-quality products and services to customers. Only by continuous innovation and breaking conventions can we remain invincible in the fierce market competition and win greater development space.

In addition, the chairman also launched the " Five Ones Strategy" for 2025, namely one product, one hall, one project, one market, and one Internet+. This strategy aims to comprehensively enhance the company's market competitiveness and brand influence through multi-dimensional layout. To ensure the effective implementation of the strategy, the chairman also proposed three strategic guidance schemes: process system management, big data management, and lean management. These schemes will help Benefit Pharmaceutical achieve remarkable results in optimizing internal processes, improving decision-making efficiency, reducing cost waste, and lay a solid foundation for the company's long-term development.

This strategic operation advanced communication meeting is not only a collision of ideas but also a call to action. We must not only work hard but also look up at the sky. Only by comprehensively doing a good job in various strategic tasks can we stay ahead of cyclical changes, stay ahead of the outbreak of future demand, enable the enterprise to have the strength to go through the cycle, develop steadily and rapidly step by step, and become an absolute benchmark in the industry. In 2025, Benefit Pharmaceutical will be guided by the spirit and measures of this strategic operation advanced communication meeting, firm its belief, and go all out to contribute to the healthy development of the group with more enthusiasm, more firm steps, and a more promising mental state!